Review reviewCritical
CVE-2023-38954
bioaccess ivs
ZKTeco BioAccess IVS v3.3.1 was discovered to contain a SQL injection vulnerability.
- CVSS
- 9.8
- EPSS
- 0.60% 45.4% percentile
- CISA KEV
- Not listed
- Published
- 2023.08.03
Review review
The CVSS severity warrants an early asset and exposure review.
Known exploitationNot established by KEV
Exploit probability0.60%
Technical severityCVSS 9.8
Vulnerability overview
ZKTeco BioAccess IVS v3.3.1 was discovered to contain a SQL injection vulnerability.
Affected product and versions
- Product
- bioaccess ivs
- Affected versions
- 3.3.1
- Fixed versions
- No verified fixed-version field is available yet
Recommended response sequence
Confirm exposure before applying a vendor-supported change.
- 1Identify
Confirm that bioaccess ivs and an affected version are present.
- 2Prioritize
Combine exploitation signals with asset exposure and business criticality.
- 3Remediate
Follow the vendor advisory or supported update path and preserve rollback options.
- 4Verify
Recheck the version, service health, access paths, and relevant logs.
Technical data
- CVSS vector
- CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- CWE
- CWE-89